LONDON, April 22, 2015 /PRNewswire/ -- The Global Cardiologist Survey is a global survey regarding end-user attitudes and perceptions towards drug-coated balloons (DCBs), transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires. Responses from interventional cardiologists from the United States and 30 other countries were gathered in person at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference. Regions include South America, Europe, Asia, Middle East and North America.Global Cardiologist Survey revealed price was the most significant consideration in product preference. The price of a DCB was considered to be one of the largest drawbacks to usage. And while this is a global trend, healthcare practitioners in Europe, Asia, Middle East and North America showed the most resistance based on product pricing.
Results also suggest a diverse coronary drug-coated balloon usage behavior. In North America 15% of respondents reported the use of drug-coated balloons in overwhelming majority of stent placement procedures. Europe's coronary DCBs usage rate however, was surveyed to be a lot less than the similar group in North America.
Aside from price, brand preferences played a significant role in a choice-worthy DCB. The IN.PACT™ Falcon was the globally preferred DCB. In Europe, where DCBs are available, SeQuent® Please was the leading product, and in the U.S., where the devices are awaiting FDA approval, Lutonix® was the leading device that would be used, be over a third of respondents.
Download the full report: https://www.reportbuyer.com/product/2462984/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48